Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam B Zeisel

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|July 31, 2015
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Gastroenterology|April 17, 2012
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodiesIsabel Fofana, Samira Fafi-Kremer, Patric Carolla, et al.
Gut|February 12, 2015
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cureMirjam B Zeisel, Julie Lucifora, William S Mason, et al.
Cell Host & Microbe|March 19, 2013
HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complexLaetitia Zona, Joachim Lupberger, Nazha Sidahmed-Adrar, et al.
Gut|February 5, 2017
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesisNicolaas Van Renne, Armando Andres Roca Suarez, Francois H T Duong, et al.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Nature Biotechnology|March 24, 2015
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|July 31, 2015
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Gastroenterology|April 17, 2012
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodiesIsabel Fofana, Samira Fafi-Kremer, Patric Carolla, et al.
Gut|February 12, 2015
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cureMirjam B Zeisel, Julie Lucifora, William S Mason, et al.
Cell Host & Microbe|March 19, 2013
HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complexLaetitia Zona, Joachim Lupberger, Nazha Sidahmed-Adrar, et al.
Gut|February 5, 2017
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesisNicolaas Van Renne, Armando Andres Roca Suarez, Francois H T Duong, et al.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Nature Biotechnology|March 24, 2015
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Pageof 11